Previous Page  217 / 232 Next Page
Information
Show Menu
Previous Page 217 / 232 Next Page
Page Background

In addition to being highly accurate, FNAB offers the

potential for a more rapid diagnosis when the cytopathologist

can make an on-site judgment. Our study found that in the 106

instances when an initial diagnosis was offered, it correlated

with final cytopathology 99.1% of the time—an improve-

ment from 92% in the predecessor study from our institu-

tion.

14

Rapid on-site diagnosis correlated with 93.3% of

histopathologic results. The ability to offer an accurate

on-site diagnosis is not only helpful in treatment planning

but also in alleviating patient and family anxiety.

The rate of nondiagnostic FNAB results is seemingly

high (n = 30, 8.9%) but was found to be lower than in a

large meta-analysis of adult HNM.

3

Current management of

such a result consists of clinical follow-up with possible

repeat FNAB or surgical excision. With these and all other

results, it is critical to remember that neither the sensitivity

nor the specificity of FNAB is 100%, and FNAB results

must be taken in the context of clinical factors.

General Anesthesia

General anesthesia or sedation was used in a significant por-

tion of the children in this study, thus nullifying one of

main benefits of FNAB. Most of these cases were thyroid

evaluations, where GA is employed routinely by policy at

our institution. While a younger average age was seen in

the nonthyroid patients undergoing FNAB with sedation or

Table 4.

Partial List of Patient Final Diagnoses.

Nonthyroid (169 Patients, 210 FNABs)

Thyroid (88 Patients, 128 FNABs)

Malignant Neoplasms

T-cell lymphoblastic lymphoma

Papillary thyroid carcinoma (13)

Diffuse large B-cell lymphoma

Medullary thyroid carcinoma

Ganglioneuroblastoma

Follicular thyroid carcinoma

Ewing’s sarcoma

Burkitt’s lymphoma

Low-grade mucoepidermoid carcinoma (parotid)

Benign Neoplasms

Pleomorphic adenoma (3)

Oncocytic adenoma (1)

Lipoma (2)

Follicular adenoma (4)

Lymphatic malformations (6)

Myofibroma

Pilomatrixoma

Desmoplastic fibroma

Benign Lesions

Benign reactive lymphadenopathy (99)

Benign colloid nodule (31)

Atypical tuberculosis (15)

Chronic lymphocytic thyroiditis (11)

Branchial cleft cyst

Hyperplastic nodule (8)

Cat scratch disease

Thyroid cyst (9)

Castleman’s disease

Multinodular goiter (2)

Cervicofacial actinomyces

Kuttner tumor

Langerhans histiocytosis

Thymic cyst (2)

Abbreviation: FNAB, fine-needle aspiration biopsy.

Table 5.

Risk of Thyroid Malignancy as cited by TBSRTC,

4

Lale et al,

19

and This Study.

a

This Study

Lale et al.

19

TBSRTC Category

TBSRTC Risk of Malignancy, % Rate of Malignancy, % FNAB, No.

Rate of Malignancy, % FNAB, No.

Nondiagnostic

1-4

0.0

9

0-25

59

Benign

0-3

2.6

77

0

136

FLUS

5-15

15.8

19

50

6

Follicular neoplasm

15-30

41.7

12

47.36

40

Suspicious for malignancy

60-75

80.0

5

100

6

Malignant

97-99

100.0

6

100

35

Abbreviations: FLUS, follicular lesion of undetermined significance; FNAB, fine-needle aspiration; TBSRTC, The Bethesda System for Reporting Thyroid

Cytopathology.

a

Rate of thyroid malignancy and number of FNABs are presented for each Bethesda System category. Rates according to TBSRTC and Lale et al

19

are pre-

sented for reference.

Huyett et al

195